𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Novel and Engineered Anti–B-Cell Monoclonal Antibodies for Non-Hodgkin’s Lymphoma

✍ Scribed by Peter Martin; Richard R. Furman; Jia Ruan; Rebecca Elstrom; Jacqueline Barrientos; Ruben Niesvizky; Morton Coleman; John P. Leonard

Book ID
117822063
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
291 KB
Volume
45
Category
Article
ISSN
1532-8686

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of B-cell non-Hodgkin's lympho
Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab
✍ Stefano Sacchi; Massimo Federico; Giuseppe Dastoli; Claudia Fiorani; Giovanni Vi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Rituximab is a chimeric anti CD-20 monoclonal antibody containing human IgG1 kappa constant regions, with murine variable regions. The anti-lymphoma effects of Rituximab are probably due to complement and antibody-dependent cell-mediated cytotoxicity, and induction of apoptosis. Phase II trials have